Vol. 31 (3) 2024 – 01

Transcription factor 7 like 2 gene polymorphism and advanced glycation end products as risk factors for diabetic nephropathy….. Original Research Article….. The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 31 (3), July, 2024 Pages: 01–14....

Vol. 31 (2) 2024 – 14

Serum Amyloid A as a non-invasive predictive biomarker of mucosal healing in ulcerative colitis patients The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 130 – 144. www.Ejimmunology.org https://doi.org/10.55133/eji.310214 Amira Isaac1, Marcel W....

Vol. 31 (2) 2024 – 13

Study of the effect of ACYP2 single nucleotide polymorphisms rs843711 and rs843706 in Egyptian patients with hepatocellular carcinoma The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 122 – 129. www.Ejimmunology.org...

Vol. 31 (2) 2024 – 12

The burden of HCV among prevalent hemodialysis patients after the National Egyptian HCV Eradication program The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 112 – 121. www.Ejimmunology.org https://doi.org/10.55133/eji.310212 Iman I. Sarhan1, Magdy...

Vol. 31 (2) 2024 – 11

Serum microRNA-16 as a potential biomarker for HCV-induced hepato-cellular carcinoma in Egyptian patients The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 102 – 111. www.Ejimmunology.org https://doi.org/10.55133/eji.310211 Amr T. El Hawary1, Fedaa...

Vol. 31 (2) 2024 – 10

The role of C-reactive protein, procalcitonin, interleukin-6 and neutrophil / lymphocyte ratio as a laboratory biomarker in COVID-19 The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 93 – 101. www.Ejimmunology.org https://doi.org/10.55133/eji.310210...